Table I.
Clinicopathological variables and miR-211 expression in 52 cervical cancer patients.
| miR-211 expression | ||||
|---|---|---|---|---|
| Characteristics | Cases (n=52) | Low (%) | High (%) | P-value |
| Age (years) | 0.7232 | |||
| ≤40 | 16 | 12 (75.0) | 4 (25.0) | |
| >40 | 36 | 28 (77.8) | 8 (22.2) | |
| Tumor size (cm) | 0.4989 | |||
| <3 | 26 | 18 (69.2) | 8 (30.8) | |
| ≥3 | 26 | 16 (61.5) | 10 (38.5) | |
| Local relapse | 0.0264a | |||
| Yes | 10 | 5 (50.0) | 5 (50.0) | |
| No | 42 | 39 (92.9) | 3 (7.1) | |
| Distant metastasis | 0.0253a | |||
| Yes | 22 | 12 (54.5) | 10 (45.5) | |
| No | 30 | 25 (83.3) | 5 (16.7) | |
| FIGO stage | 0.0395a | |||
| IB | 28 | 16 (57.1) | 12 (42.9) | |
| IIA | 24 | 16 (66.7) | 8 (33.3) | |
| Differentiation | 0.3158 | |||
| Well | 14 | 8 (57.1) | 6 (42.9) | |
| Moderate/poor | 38 | 26 (68.4) | 12 (31.6) | |
a
P<0.05.